title: Economic implications and cost-effectiveness of implantable cardioverter defibrillator and cardiac resynchronization therapy.
abstract: Use of implantable cardioverter defibrillators (ICDs) and/or cardiac resynchronization therapy reduces mortality among several high-risk cohorts, primarily those with left ventricular systolic dysfunction and heart failure. Since the advent of these technologies, concerns regarding the high initial costs of device implantation have been considered a potential barrier to widespread adoption. Despite such concerns, the use of these devices for primary or secondary prevention of sudden cardiac death seems to be cost-effective when compared with national standards. Moreover, ICDs have been shown to be cost-effective in several health care systems and specialized populations such as those with high-risk long QT syndrome and hypertrophic cardiomyopathy.
authors: Division of Cardiology, Medical University of South Carolina, ART 7031, MSC 592, Charleston, SC 29425, USA.
authors: Michael L
authors: ML
authors: Bernard
authors: Michael R
authors: MR
authors: Gold
mesh_terms: D002304:Cardiac Pacing, Artificial / Q000191:economics*; D003362:Cost-Benefit Analysis; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D017147:Defibrillators, Implantable / Q000191:economics*; D018450:Disease Progression; D006333:Heart Failure / Q000191:economics / Q000628:therapy*; D006801:Humans; D011322:Primary Prevention; D019057:Quality-Adjusted Life Years; D055502:Secondary Prevention; D014481:United States